This DEA action will likely contribute to increases in the “hazard to the public safety” associated with this synthetic analogue of fentanyl. By claiming to do the opposite in assigning furanylfentanyl to Schedule I this counterproductive move will prop up the black market and fail in its stated mission, just as it has with heroin and Schedule II fentanyl as well as countless other “controlled” drugs.
By assigning the drug to Schedule I DEA only insures that when purchased on the street users will not know the dose or quality of what they use and will not have the advantage of warning labels, thus increasing the risks.
- “a high potential for abuse”: No more than alcohol which adults can purchase from grocery stores.
- “no currently accepted medical use in treatment in the United States”: Probably no less than fentanyl itself, and only since no pharmaceutical company has invested hundreds of millions of dollars to satisfy onerous FDA requirements.
- “and a lack of accepted safety for use under medical supervision”: What “medical supervision” do we allow for users of heroin? In reality, “medical supervision” of comparable opiate analgesics prescribed to outpatients ends once the pharmacist dispenses the drug to the patient.
- “Evidence suggests that the pattern of abuse of fentanyl analogues, including furanyl fentanyl, parallels that of heroin and prescription opioid analgesics.” Has current drug policy helped?
- “The DEA is currently aware of at least 128 confirmed fatalities associated with furanyl fentanyl.” Small potatoes compared to alcohol and tobacco.
In my opinion the best strategy to save lives from all these drugs would involve regulation of legitimate manufacture to include quality and dose standards, education and labeling rather than the now prevalent delusion of control.
We must repeal the Controlled Substances Act of 1970 and eliminate DEA in order to minimize or even eliminate the dangerous black market in drugs and minimize harm to Americans.